IMMUPHARMA PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.165 GBX | +6.91% |
|
+13.95% | +29.87% |
| Apr. 29 | Immunovia Announces the Appointment of Lisa Fordas as Clinical Laboratory Director | CI |
| Apr. 02 | Immupharma jumps amid new IP strategy for P140 technology platform | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 11.28M | - | - | - | - | - | |
| 44.96B | - | |||||
| 42.65B | ||||||
| 41.85B | ||||||
| 29.04B | ||||||
| 26.08B |
- Stock Market
- Equities
- IMM Stock
- Charts ImmuPharma plc
- Sector Chart